1,4,8,12-TETRAAZACYCLOPENTADECANE,MIN. 98%
Product Information
Molecular Formula
C11H26N4
Molecular Weight
214.35
Description
1,4,8,12-Tetraazacyclopentadecane is primarily utilized in biomedical research, specifically in the development of potential cancer treatment drugs. Its unique structure allows for versatile metal ion complexation, crucial in anticancer agents.
Synonyms
1,4,8,12-Tetraazacyclopentadecane; 1,4,8,12-tetrazacyclopentadecane; 1,4,8,12-Tetraazacyclopentadecane, 97%
IUPAC Name
1,4,8,12-tetrazacyclopentadecane
SMILES
C1CNCCCNCCNCCCNC1
InChI
InChI=1S/C11H26N4/c1-4-12-6-2-8-14-10-11-15-9-3-7-13-5-1/h12-15H,1-11H2
InChI Key
KUFDRRWNPNXBRF-UHFFFAOYSA-N
Melting Point
96-102 °C (lit.)
Flash Point
Not applicable
Purity
0.97
Safety Information
Hazards
H315 - H319 - H335
Precautionary Statement
P302 + P352 - P305 + P351 + P338
Computed Properties
XLogP3
-0.6
Hydrogen Bond Donor Count
4
Hydrogen Bond Acceptor Count
4
Rotatable Bond Count
0
Exact Mass
214.21574685 g/mol
Monoisotopic Mass
214.21574685 g/mol
Topological Polar Surface Area
48.1Ų
Heavy Atom Count
15
Formal Charge
0
Complexity
116
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| JP-2021080483-A | Complex | 2021-03-04 |
| WO-2022042977-A1 | Detergent composition | 2020-08-28 |
| WO-2022042989-A1 | Surfactant and detergent composition | 2020-08-28 |
| WO-2022043042-A1 | Detergent composition | 2020-08-28 |
| WO-2022043045-A1 | Detergent composition | 2020-08-28 |
| WO-2022043138-A1 | Surfactant and detergent composition | 2020-08-28 |
| JP-2022032446-A | Fiber treatment agent composition | 2020-08-12 |
| WO-2022024054-A1 | Odorants and compositions comprising odorants | 2020-07-31 |
| EP-3940806-A1 | Method of modifying the structure of perovskite films | 2020-07-14 |
| EP-3936593-A1 | Cleaning compositions and uses thereof | 2020-07-08 |
Literatures
| PMID | Publication Date | Title | Journal |
|---|---|---|---|
| 20128813 | 2010-05-01 | Nitric oxide donor trans-[RuCl([15]aneN)NO] as a possible therapeutic approach for Chagas' disease | British journal of pharmacology |
| 19114114 | 2009-05-01 | Hypotensive effect of the nitrosyl ruthenium complex nitric oxide donor in renal hypertensive rats | Nitric oxide : biology and chemistry |
| 21200551 | 2007-12-18 | [(1-Azulen-yl)methane-thiol-ato-κS](1,4,8,12-tetra-azacyclo-penta-decane-κN)zinc(II) perchlorate | Acta crystallographica. Section E, Structure reports online |
| 16759899 | 2006-12-01 | Structural and spectroscopic properties of trans-difluoro(1,4,8,12-tetraazacyclopentadecane)chromium(III) perchlorate hydrate | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy |
| 16054406 | 2005-11-01 | The complex trans-[RuCl([15]aneN4NO]2+ induces rat aorta relaxation by ultraviolet light irradiation | Nitric oxide : biology and chemistry |
| 15135361 | 2004-03-01 | A macrocyclic nitrosyl ruthenium complex is a NO donor that induces rat aorta relaxation | Nitric oxide : biology and chemistry |
| 9875379 | 1998-01-01 | Design, synthesis and structure relationships of new N,N',N',N''-tetrakis (omega-amino alkyl) tetraazamacrocycles | Antiviral chemistry & chemotherapy |
| 7276 | 1976-01-01 | [Drug-drug interactions (author's transl)] | Arzneimittel-Forschung |
